Objective: To investigate the relative bioavailability and bioequivalence, in fasting and fed conditions, of repeated doses of two omeprazole enteric-coated formulations in healthy volunteers.

Background: Anew formulation of enteric-coated oral fluoxetine given at a dose of 90mg once weekly has been shown in clinical trials to be well tolerated, safe, effective and associated with very ...

BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity: Vancouver, BC Wednesday, November 27, 2024, 17:00 ...